Page last updated: 2024-08-17

nad and erlotinib hydrochloride

nad has been researched along with erlotinib hydrochloride in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Baek, M; Cheon, SH; Cho, S; Choi, Y; Chung, SJ; Jeong, YS; Jung, KY; Kim, D; Kim, DG; Kim, HS; Koh, CH; Koo, JS; Lee, BJ; Lee, HH; Lee, JY; Lee, KY; Lee, SJ; Lim, HJ; Oh, YK; Park, SJ; Shin, KS; Yoon, HJ	1

Other Studies

1 other study(ies) available for nad and erlotinib hydrochloride

Article	Year
Crystal structures of human NSDHL and development of its novel inhibitor with the potential to suppress EGFR activity. Cellular and molecular life sciences : CMLS, 2021, Volume: 78, Issue:1 Topics: 3-Hydroxysteroid Dehydrogenases; Binding Sites; Cell Line, Tumor; Cell Survival; Cholesterol; Crystallography, X-Ray; Enzyme Inhibitors; ErbB Receptors; Erlotinib Hydrochloride; Humans; Kinetics; Molecular Docking Simulation; Mutagenesis, Site-Directed; NAD; Protein Structure, Tertiary; Recombinant Proteins; Signal Transduction	2021

Article

Year

Crystal structures of human NSDHL and development of its novel inhibitor with the potential to suppress EGFR activity.

Cellular and molecular life sciences : CMLS, 2021, Volume: 78, Issue:1

Topics: 3-Hydroxysteroid Dehydrogenases; Binding Sites; Cell Line, Tumor; Cell Survival; Cholesterol; Crystallography, X-Ray; Enzyme Inhibitors; ErbB Receptors; Erlotinib Hydrochloride; Humans; Kinetics; Molecular Docking Simulation; Mutagenesis, Site-Directed; NAD; Protein Structure, Tertiary; Recombinant Proteins; Signal Transduction

2021